HuidaGene Therapeutics Announces Publication of the World’s First Guanine Base-Editor

SHANGHAI and CLINTON, N.J., May 18, 2023 /PRNewswire/ — HuidaGene Therapeutics (辉大基因; HuidaGene), a clinical-stage genome-editing company, today announced the online National Science Review published the comprehensive data from a study of the world’s first DNA base editor converting…

Leave a Reply

Your email address will not be published. Required fields are marked *